1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hypertension, Pulmonary in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (17.39) | 18.7374 |
| 1990's | 34 (73.91) | 18.2507 |
| 2000's | 3 (6.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, J; Moriyama, H | 1 |
| Gutbier, B; Ishii, S; Mayer, K; Mitchell, TJ; Owen, JS; Rosseau, S; Schmeck, B; Schütte, H; Suttorp, N; Thomas, MJ; Witzenrath, M | 1 |
| Chen, H; Wang, H; Wang, YL; Xia, SH; Xu, W | 1 |
| Hechtman, HB; Shepro, D; Valeri, CR | 1 |
| Canham, EM; Heffner, JE; McMurtry, IF; Morris, HG; Patel, M; Repine, JE; Shoemaker, SA | 2 |
| Chen, W; Cheng, D; Yang, X | 2 |
| Argiolas, L; del Basso, P; Fabi, F | 1 |
| Endres, S; Kohl, J; Machleidt, W; Siebeck, M; Spannagl, M | 1 |
| Ma, CT | 1 |
| Ashino, Y; Fujimura, S; Hoshikawa, Y; Nishimura, T; Noda, M; Ono, S; Tabata, S; Tanita, T; Ueda, S | 1 |
| Chen, WB; Cheng, DY | 1 |
| Johnson, LW; Kruse-Elliott, KT; Olson, NC | 1 |
| Huang, YC; Kennedy, TP; Piantadosi, CA; Su, YF; Watkins, WD; Whorton, AR | 1 |
| Goldsmith, JA; Kavanagh, BP; Pearl, RG | 1 |
| Atkinson, J; Berkeland, J; Emil, S; Kosi, M | 1 |
| Chen, W; Cheng, D | 3 |
| Belenkov, Yu; Chazova, I; Gabbasov, Z; Nakonechnicov, S; Popov, E | 1 |
| Chen, D; Chen, W | 1 |
| Koyama, S; Matsuda, Y; Shibamoto, T; Wang, HG | 1 |
| Asada, A; Hayashi, M; Inoue, M; Yamada, T; Yukioka, H | 1 |
| Tuder, RM; Voelkel, NF | 1 |
| Abu-Zidan, FM; Karlsson, H; Lennquist, S; Walther, S | 1 |
| Ding, JS; He, JL; Li, HP; Quan, CJ | 1 |
| Delong, P; Hubbard, CL; Huggins, E; McCall, C; O'Sullivan, MG | 1 |
| Quinn, JV; Slotman, GJ | 1 |
| Goldfarb, R | 1 |
| Carter, MB; Clavijo, LC; Garrison, RN; Matheson, PJ; Wead, WB; Wills-Frank, LA; Wilson, MA | 1 |
| Ono, S; Voelkel, NF | 2 |
| Ono, S; Voelkel, NF; Westcott, JY | 1 |
| Davidson, D; Drafta, D | 1 |
| Andrew, M; Coles, J; Rabinovitch, M; Trusler, GA; Turner-Gomes, SO; Williams, WG | 1 |
| DeMello, D; Lagunoff, D; Ohar, JA; Waller, KS | 1 |
| Davidson, D; Singh, M; Wallace, GF | 1 |
| Brendel, W; Conzen, PF; Gutmann, R; Habazettl, H; Hobbhahn, J; Peter, K; Vollmar, B; Yekebas, E | 1 |
| Barnes, PJ; Evans, TW; McCormack, DG | 1 |
| Hyers, TM; Lagunoff, D; Ohar, JA; Pyle, JA; Waller, KS; Webster, RO | 1 |
| Gasser, H; Krautschneider, S; Paul, E; Redl, H; Schiesser, A; Schlag, G; Thurnher, M; Vogl, C | 1 |
| McDonald, JW; Smallbone, BW; Taylor, NE | 1 |
| Becher, G; Kühn, H; Schewe, T; Schilling, W; Slapke, J | 1 |
| Imai, T; Jacob, HS; Moldow, CF; Vercellotti, GM; Weir, EK | 1 |
| Mlczoch, J | 1 |
6 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Pathophysiological Involvement of Mast Cells and the Lipid Mediators in Pulmonary Vascular Remodeling.
Topics: Eicosanoids; Epoxy Compounds; Humans; Hypertension, Pulmonary; Mast Cells; Platelet Activating Factor; Vascular Remodeling | 2023 |
Role of platelet activating factor in pathogenesis of acute respiratory distress syndrome.
Topics: Animals; Humans; Hypertension, Pulmonary; Inflammation Mediators; Neutrophil Activation; Platelet Activating Factor; Pulmonary Edema; Respiratory Distress Syndrome | 2007 |
Role of humoral mediators in adult respiratory distress syndrome.
Topics: Animals; Arachidonic Acids; Chemotaxis, Leukocyte; Chromones; Dogs; Guinea Pigs; Humans; Hypertension, Pulmonary; Inflammation; Ketanserin; Leukocyte Count; Leukocytes; Lung; Piperidines; Platelet Activating Factor; Pulmonary Embolism; Respiratory Distress Syndrome; Serotonin; Serotonin Antagonists; SRS-A; Thromboxane A2 | 1984 |
[The current status of the research on platelet activating factor and pulmonary hypertension].
Topics: Humans; Hypertension, Pulmonary; Platelet Activating Factor; Pulmonary Circulation | 1993 |
Pulmonary hypertension and inflammation.
Topics: Animals; Arachidonate 5-Lipoxygenase; Endothelial Growth Factors; Endothelins; Humans; Hypertension, Pulmonary; Inflammation; Insulin-Like Growth Factor I; Lymphokines; Platelet Activating Factor; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Investigations into the polydeterminant nature of sepsis.
Topics: Animals; Arachidonic Acid; Eicosanoids; Heart Diseases; Humans; Hypertension, Pulmonary; Platelet Activating Factor; Shock, Septic; Tumor Necrosis Factor-alpha | 1999 |
40 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Role of platelet-activating factor in pneumolysin-induced acute lung injury.
Topics: Animals; Bacterial Proteins; Disease Models, Animal; Female; Humans; Hypertension, Pulmonary; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Pneumonia, Pneumococcal; Protein Serine-Threonine Kinases; Respiratory Distress Syndrome; rho-Associated Kinases; Signal Transduction; Streptolysins; Thromboxane A2 | 2007 |
Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2.
Topics: Animals; Blood Platelets; Female; Hypertension, Pulmonary; Imidazoles; Lung; Male; Perfusion; Platelet Activating Factor; Pressure; Prostanoic Acids; Pulmonary Edema; Rabbits; Thromboxane A2 | 1983 |
Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2.
Topics: Albumins; Animals; Blood Platelets; Hypertension, Pulmonary; Lung; Neutrophils; Platelet Activating Factor; Pulmonary Edema; Rabbits; Thromboxane A2; Thromboxanes | 1983 |
[Acute effects of platelet activating factor on the pulmonary circulation in rats].
Topics: Animals; Blood Pressure; Cardiac Output; Hypertension, Pulmonary; Male; Platelet Activating Factor; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Wistar | 1995 |
Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: role of platelets and cyclo-oxygenase metabolites.
Topics: Animals; Blood Platelets; Blood Pressure; Bronchoconstriction; Cardiac Output; Dose-Response Relationship, Drug; Guinea Pigs; Heart Rate; Hypertension, Pulmonary; Male; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats | 1995 |
Delayed treatment with platelet activating factor receptor antagonist web 2086 attenuates pulmonary dysfunction in porcine endotoxin shock.
Topics: Animals; Azepines; Blood Pressure; Cathepsin B; Creatinine; Extravascular Lung Water; Hypertension, Pulmonary; Lipopolysaccharides; Lung; Platelet Activating Factor; Pulmonary Artery; Pulmonary Gas Exchange; Salmonella; Shock, Septic; Swine; Swine, Miniature; Triazoles; Tumor Necrosis Factor-alpha; Vascular Resistance | 1994 |
[Variation of plasma platelet activating factor during development and reversal of hypoxic pulmonary hypertension in conscious sheep].
Topics: Animals; Female; Hypertension, Pulmonary; Hypoxia; Platelet Activating Factor; Radioimmunoassay; Sheep; Vasoconstriction | 1994 |
[Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
Topics: Animals; Azepines; DNA; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thymidine; Triazoles | 1994 |
Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Azepines; Blood; Calcimycin; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Hemodynamics; Hypertension, Pulmonary; In Vitro Techniques; Indomethacin; Infusions, Intra-Arterial; Leukotriene B4; Lipoxygenase Inhibitors; Naphthoquinones; ortho-Aminobenzoates; Platelet Activating Factor; Swine; Thromboxane B2; Triazoles | 1993 |
Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung.
Topics: Animals; Arachidonic Acids; Benzoquinones; Blood Pressure; Bronchoconstriction; Humans; Hypertension, Pulmonary; In Vitro Techniques; Indicators and Reagents; Indomethacin; Interferon Inducers; Interferon Type I; Lipoxygenase Inhibitors; Lung Diseases; Male; Microcirculation; Platelet Activating Factor; Poly I-C; Pulmonary Edema; Rabbits; Recombinant Proteins; Vascular Resistance | 1993 |
Plasma potentiates the priming effects of endotoxin on platelet activating factor-induced pulmonary hypertension in the rabbit lung.
Topics: Acute-Phase Proteins; Animals; Blood Pressure; Blood Proteins; Carrier Proteins; Disease Models, Animal; Endotoxins; Escherichia coli; Hypertension, Pulmonary; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Membrane Glycoproteins; Plasma; Platelet Activating Factor; Pulmonary Artery; Rabbits; Respiratory Distress Syndrome; Serum Albumin | 1996 |
Inhaled nitric oxide prevents experimental platelet activating factor-induced shock.
Topics: Administration, Inhalation; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hypertension, Pulmonary; Nitric Oxide; Platelet Activating Factor; Random Allocation; Shock, Septic; Swine | 1996 |
[Effects of ginkgolide B on isobaric hypoxic pulmonary hypertension in rats].
Topics: Animals; Diterpenes; Ginkgolides; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lactones; Male; Platelet Activating Factor; Rats; Rats, Wistar | 1995 |
Platelet aggregation in patients with primary pulmonary hypertension.
Topics: Adenosine Diphosphate; Blood Platelets; Humans; Hypertension, Pulmonary; Kinetics; Platelet Activating Factor; Platelet Aggregation; Prognosis | 1996 |
Changes of distribution of platelet activating factor in the lung of rats with hypoxic pulmonary hypertension.
Topics: Animals; Arterioles; Hypertension, Pulmonary; Hypoxia; Lung; Male; Platelet Activating Factor; Pulmonary Alveoli; Rats; Rats, Wistar | 1996 |
Effects of ginkgolide B on isobaric hypoxic pulmonary hypertension in rats.
Topics: Animals; Arterioles; Diterpenes; Ginkgolides; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Lactones; Lung; Male; Platelet Activating Factor; Rats; Rats, Wistar | 1996 |
[The level of platelet activating factor in blood of rats with hypoxic pulmonary hypertension].
Topics: Animals; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Platelet Activating Factor; Rats; Rats, Wistar | 1996 |
[The role of platelet activating factor in chronic pulmonary hypertension].
Topics: Animals; Arterioles; Blood Pressure; Hypertension, Pulmonary; Lung; Male; Platelet Activating Factor; Pulmonary Artery; Rats; Rats, Wistar; Vascular Resistance | 1996 |
The role of endogenous nitric oxide in the sympathetic and hemodynamic response to platelet activating factor-induced hypotension in anesthetized dogs.
Topics: Anesthetics; Animals; Blood Gas Analysis; Blood Pressure; Dogs; Enzyme Inhibitors; Female; Hematocrit; Hemodynamics; Hypertension, Pulmonary; Hypotension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Activating Factor; Sympathetic Nervous System; Vasomotor System | 1998 |
Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Hemoglobins; Hypertension, Pulmonary; Injections, Intravenous; Methemoglobin; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oxygen; Platelet Activating Factor; Pulmonary Circulation; Vasoconstrictor Agents | 1998 |
Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs.
Topics: Animals; Anticoagulants; Drug Antagonism; Female; Heparin; Hypertension, Pulmonary; Injections, Intravenous; Male; Platelet Activating Factor; Swine | 1998 |
[The relationship between the activity of phospholipase A2 and acute hypoxic pulmonary arterial pressure].
Topics: Animals; Dinoprostone; Female; Hypertension, Pulmonary; Hypoxia; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Random Allocation; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1997 |
Bacterial lipopolysaccharide induction of the prostaglandin G/H synthase 2 gene causes thromboxane-dependent pulmonary hypertension in rabbits.
Topics: Animals; Arachidonic Acid; Cycloheximide; Cyclooxygenase 1; Cyclooxygenase 2; Dactinomycin; Drug Interactions; Enzyme Induction; Female; Hypertension, Pulmonary; In Vitro Techniques; Isoenzymes; Lipopolysaccharides; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rabbits; Thromboxanes | 1999 |
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Topics: Aeromonas hydrophila; Animals; Arachidonic Acid; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Eicosanoids; Female; Gram-Negative Bacterial Infections; Heart Diseases; Hemodynamics; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Masoprocol; Oxazoles; Oxygen; Oxygen Consumption; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Swine; Thromboxane A2; Triazoles; Tumor Necrosis Factor-alpha | 1999 |
Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Topics: Animals; Bacteremia; Endothelin-1; Escherichia coli Infections; Hemodynamics; Hemoglobins; Hypertension, Pulmonary; Male; Neutrophils; Nitric Oxide; Oxygen; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 2000 |
PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model.
Topics: Animals; Azepines; Blood Pressure; Hydroxyproline; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pulmonary Artery; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thymidine; Triazoles | 1992 |
PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
Topics: Animals; Azepines; Endothelins; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pulmonary Circulation; Rats; Triazoles; Vasoconstriction | 1992 |
Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung.
Topics: Animals; Arachidonate 5-Lipoxygenase; Diethylcarbamazine; Hypertension, Pulmonary; In Vitro Techniques; Lipoxygenase Inhibitors; Lung; Male; Perfusion; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; SRS-A | 1992 |
Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease.
Topics: Antithrombin III; Cardiopulmonary Bypass; Child; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Platelet Activating Factor; Postoperative Complications; Protein C; Pulmonary Embolism; von Willebrand Factor | 1992 |
Administration of chronic intravenous platelet-activating factor induces pulmonary arterial atrophy and hypertension in rabbits.
Topics: Animals; Atrophy; Cardiomegaly; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Platelet Activating Factor; Pulmonary Artery; Rabbits | 1991 |
PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
Topics: Animals; Azepines; Cardiomegaly; Hypertension, Pulmonary; Lung; Lung Injury; Male; Monocrotaline; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles | 1991 |
Role of leukotriene C4 in pulmonary hypertension: platelet-activating factor vs. hypoxia.
Topics: Animals; Cyclooxygenase Inhibitors; Hypertension, Pulmonary; Hypoxia; Indomethacin; Kinetics; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A | 1990 |
Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
Topics: Animals; Azepines; Clemastine; Hemodynamics; Heparin Antagonists; Hypertension, Pulmonary; Platelet Activating Factor; Protamines; Ranitidine; Swine; Triazoles | 1990 |
Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
Topics: Animals; Azepines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Injections, Intravenous; Male; Platelet Activating Factor; Pulmonary Circulation; Swine; Triazoles; Vascular Resistance; Vasoconstriction | 1990 |
A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorylcholine.
Topics: Animals; Blood Cell Count; Body Weight; Bronchi; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Extravascular Lung Water; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Platelet Activating Factor; Platelet Aggregation; Pulmonary Alveoli; Pulmonary Artery; Rabbits | 1990 |
Effect of platelet-activating factor (PAF) administration in chronically instrumented sheep--analysis of PAF in plasma.
Topics: Animals; Blood Pressure; Cardiac Output; Chromatography, High Pressure Liquid; Hypertension, Pulmonary; Lung; Lymph; Platelet Activating Factor; Sheep; Vascular Resistance | 1989 |
Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
Topics: Animals; Aspirin; Complement Activation; Complement System Proteins; Dose-Response Relationship, Drug; Endotoxins; Female; Furans; Hypertension, Pulmonary; Hypoxia; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sheep; Thromboxanes; Zymosan | 1987 |
[Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension].
Topics: Animals; Arachidonic Acids; Asthma; Disease Models, Animal; Drug Evaluation, Preclinical; Guinea Pigs; Humans; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Platelet Activating Factor; Pulmonary Artery; Rabbits | 1988 |
Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
Topics: Animals; Diterpenes; Edema; Furans; Ginkgolides; Hypertension, Pulmonary; Injections, Intra-Arterial; Lactones; Lung; Male; Organ Size; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1988 |
[Disorders of thrombocyte function and/or endothelial cell damage as a cause of primary pulmonary hypertension?].
Topics: Animals; Blood Platelets; Endothelium; Epoprostenol; Fibrinolysis; Humans; Hypertension, Pulmonary; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Pulmonary Artery | 1986 |